Nuvation Bio Inc. Quarterly Debt-to-equity in % from Q2 2021 to Q3 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Nuvation Bio Inc. quarterly Debt-to-equity history and growth rate from Q2 2021 to Q3 2024.
Nuvation Bio Inc. Debt-to-equity for the quarter ending September 30, 2024 was 8.52 %, a 212% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	8.52	+5.79	+212%	Sep 30, 2024
Q2 2024	5.68	+3.04	+115%	Jun 30, 2024
Q1 2024	2.94	-0.01	-0.34%	Mar 31, 2024
Q4 2023	2.76	-0.55	-16.6%	Dec 31, 2023
Q3 2023	2.73	-0.93	-25.4%	Sep 30, 2023
Q2 2023	2.64	-1.23	-31.8%	Jun 30, 2023
Q1 2023	2.95	-0.76	-20.5%	Mar 31, 2023
Q4 2022	3.3	-0.22	-6.24%	Dec 31, 2022
Q3 2022	3.66	+0.32	+9.58%	Sep 30, 2022
Q2 2022	3.87	+0.78	+25.3%	Jun 30, 2022
Q1 2022	3.7			Mar 31, 2022
Q4 2021	3.52			Dec 31, 2021
Q3 2021	3.34			Sep 30, 2021
Q2 2021	3.09			Jun 30, 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.